Gracell Biotechnologies Inc - ADR

NASDAQ:GRCL   3:59:54 PM EDT
13.24
-0.44 (-3.22%)
Earnings Announcements

Gracell Biotechnologies Reports Fourth Quarter And Fiscal Year 2020 Unaudited Financial Results

Published: 03/09/2021 22:58 GMT
Gracell Biotechnologies Inc - ADR (GRCL) - Gracell Biotechnologies Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results and Provides Corporate Update.
Gracell Biotechnologies Inc - Net Loss Attributable to Ordinary Shareholders for Three Months Ended December 31, 2020 Was Rmb99.9 Million (us$15.3 Million).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.